Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to learn if islet transplantation is an effective treatment for
Type 1 diabetes in people who have had a kidney transplant.
The primary objectives of the study are:
- To set up islet transplantation in patients who have had a kidney transplant and who are
using an immunosuppressive regimen that works
The Secondary objective of the study is:
- To find out if successful islet transplantation leads to improved metabolic control and
reduced renal complication from diabetes
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Boston Area Diabetes Endocrinology Research Center (funded by NIDDK)